Galmed Pharmaceuticals Ltd.
GLMD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $3,314 | $4,964 | $4,767 | $4,652 |
| Short-Term Investments | $15,737 | $15,564 | $10,962 | $10,679 |
| Receivables | $549 | $433 | $447 | $209 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $124 | $123 | $122 | $121 |
| Total Curr. Assets | $19,724 | $21,084 | $16,298 | $16,124 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $1,593 | $1,593 | $2,119 | $2,119 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $267 | $267 | $267 | $257 |
| Total NC Assets | $1,860 | $1,860 | $2,386 | $2,376 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $21,584 | $22,944 | $18,684 | $18,500 |
| Liabilities | – | – | – | – |
| Payables | $1,674 | $1,369 | $1,308 | $1,308 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $798 | $0 | $0 | $603 |
| Total Curr. Liab. | $2,472 | $2,421 | $1,807 | $2,173 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $2,472 | $2,421 | $1,807 | $2,173 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $2,786 | $2,690 | $1,029 | $742 |
| Retained Earnings | -$205,960 | -$204,068 | -$201,573 | -$200,469 |
| AOCI | -$316 | -$403 | -$397 | -$416 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $19,112 | $20,523 | $16,877 | $16,327 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $21,584 | $22,944 | $18,684 | $18,500 |
| Net Debt | -$3,314 | -$4,964 | -$4,767 | -$4,652 |